Bioorganic and Medicinal Chemistry Letters p. 2888 - 2892 (2013)
Update date:2022-07-29
Topics:
Kim, Se-Ho
Markovitz, Benjamin
Trovato, Richard
Murphy, Brett R.
Austin, Harry
Willardsen, Adam J.
Baichwal, Vijay
Morham, Scott
Bajji, Ashok
A new oxazole scaffold showing great promise in HIV-1 inhibition has been discovered by cell-based screening of an in-house library and scaffold modification. Follow-up SAR study focusing on the 5-aryl substituent of the oxazole core has identified 4k (EC50 = 0.42 μM, TI = 50) as a potent inhibitor. However, the analogues suffered from poor aqueous solubility. To address this issue, we have developed broadly applicable potential prodrugs of indazoles. Among them, N-acyloxymethyl analogue 11b displayed promising results (i.e., increased aqueous solubility and susceptibility to enzymatic hydrolysis). Further studies are warranted to fully evaluate the analogues as the potential prodrugs with improved physiochemical and PK properties
View MoreShanghai Hohance Chemical Co., ltd
Contact:13914753421
Address:Fl.5;Bld. 70, Lane 1500; Xinfei Road
Zhengzhou Yuanli Biological Technology Co., Ltd.
Contact:+86-371-67897870/67897895
Address:No. 38, Qingyang Street, Zhengzhou, Henan, China
Guangzhou Chemical Reagent Factory
Contact:+86-20-8435 9820 or 8435 7345
Address:Southern Guangzhou, Guangdong, China
Guangzhou PI & PI Biotech Inc. Ltd.
Contact:+86-20-81716320
Address:Suite 501,198 Kaiyuan Ave.,Science City, Guangzhou,China
Nanjing Fayekong Chemcial Co.,Ltd(expird)
Contact:86-25-58813444
Address:Rm 1503, Unit 1, Building 5, Zijinnanyuan, Nanjing, Jiangsu, China
Doi:10.1016/j.jorganchem.2011.03.035
(2011)Doi:10.1158/0008-5472.CAN-09-3736
(2010)Doi:10.1021/jo1025223
(2011)Doi:10.1002/chem.201002822
(2011)Doi:10.1246/bcsj.20100154
(2011)Doi:10.1016/j.bmcl.2011.01.054
(2011)